IMPACT SCORE JOURNAL RANKING CONFERENCE RANKING Conferences Journals Workshops Seminars SYMPOSIUMS MEETINGS BLOG LaTeX 5G Tutorial Free Tools

Search About Journals, Conferences, and Book Series

Signal Transduction and Targeted Therapy

Impact, Factor and Metrics, Impact Score, Ranking, h-index, SJR, Rating, Publisher, ISSN, and More

Last Updated on October 31, 2023

Impact Score

2022-2023

18.94

h-Index

2022-2023

 83

Rank

2022-2023

 156

SJR

2022-2023

 6.630

Note: The impact score or impact index shown here is equivalent to the average number of times documents published in a journal/conference in the past two years have been cited in the current year (i.e., Cites / Doc. (2 years)). It is based on Scopus data and can be a little higher or different compared to the impact factor (IF) produced by Journal Citation Report. Please refer to the Web of Science data source to check the exact journal impact factor ™ (Thomson Reuters) metric.

Important Metrics and Factor

Title Signal Transduction and Targeted Therapy
Abbreviation Signal Transduct. Target. Ther.
Publication Type Journal
Subject Area, Categories, Scope Cancer Research (Q1); Genetics (Q1)
h-index 83
Overall Rank/Ranking 156
SCImago Journal Rank (SJR) 6.630
Impact Score 18.94
Publisher Springer Nature
Country United Kingdom
ISSN 20593635, 20959907
Best Quartile Q1
Coverage History 2016-2022




About Signal Transduction and Targeted Therapy


Signal Transduction and Targeted Therapy is a journal covering the technologies/fields/categories related to Cancer Research (Q1); Genetics (Q1). It is published by Springer Nature. The overall rank of Signal Transduction and Targeted Therapy is 156. According to SCImago Journal Rank (SJR), this journal is ranked 6.630. SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come. SJR acts as an alternative to the Journal Impact Factor (or an average number of citations received in last 2 years). This journal has an h-index of 83. The best quartile for this journal is Q1.

The ISSN of Signal Transduction and Targeted Therapy journal is 20593635, 20959907. An International Standard Serial Number (ISSN) is a unique code of 8 digits. It is used for the recognition of journals, newspapers, periodicals, and magazines in all kind of forms, be it print-media or electronic. Signal Transduction and Targeted Therapy is cited by a total of 14639 articles during the last 3 years (Preceding 2022).


Signal Transduction and Targeted Therapy Impact IF 2022-2023


The Impact IF 2022 of Signal Transduction and Targeted Therapy is 18.94, which is computed in 2023 as per its definition. Signal Transduction and Targeted Therapy IF is increased by a factor of 1.53 and approximate percentage change is 8.79% when compared to preceding year 2021, which shows a rising trend. The impact IF, also denoted as Journal impact score (JIS), of an academic journal is a measure of the yearly average number of citations to recent articles published in that journal. It is based on Scopus data.

Table Setting

Signal Transduction and Targeted Therapy Impact IF 2023 Prediction


Impact IF 2022 of Signal Transduction and Targeted Therapy is 18.94. If the same upward trend persists, Impact IF may rise in 2023 as well.


Impact IF Trend


Year wise Impact IF of Signal Transduction and Targeted Therapy. Based on Scopus data.


Year Impact IF
2023/2024 Coming Soon
2022 18.94
2021 17.41
2020 12.91
2019 13.78
2018 6.00
2017 5.52
2016 0.00

Signal Transduction and Targeted Therapy h-index


  Table Setting

Signal Transduction and Targeted Therapy has an h-index of 83. It means 83 articles of this journal have more than 83 number of citations. The h-index is a way of measuring the productivity and citation impact of the publications. The h-index is defined as the maximum value of h such that the given journal/author has published h papers that have each been cited at least h number of times.




Signal Transduction and Targeted Therapy ISSN


The ISSN of Signal Transduction and Targeted Therapy is 20593635, 20959907. ISSN stands for International Standard Serial Number.

An ISSN is a unique code of 8 digits. It is used for the recognition of journals, newspapers, periodicals, and magazines in all kind of forms, be it print-media or electronic.

Table Setting

Signal Transduction and Targeted Therapy Rank and SCImago Journal Rank (SJR)


The overall rank of Signal Transduction and Targeted Therapy is 156. According to SCImago Journal Rank (SJR), this journal is ranked 6.630. SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come.

SJR of Signal Transduction and Targeted Therapy by Year


Year SJR
2023/2024 Coming Soon
2022 6.630
2021 5.157
2020 4.284
2019 3.755
2018
2017
2016

Ranking of Signal Transduction and Targeted Therapy by Year


Year Ranking
2023/2024 Coming Soon
2022 156
2021 250
2020 357
2019 437
2018 33911
2017 34677
2016 34114

Signal Transduction and Targeted Therapy Publisher


Table Setting

Signal Transduction and Targeted Therapy is published by Springer Nature. It's publishing house is located in United Kingdom. Coverage history of this journal is as following: 2016-2022. The organization or individual who handles the printing and distribution of printed or digital publications is known as Publisher.


Call For Papers


Visit the official website of the journal/conference to check the further details about the call for papers.


Abbreviation


The IS0 4 standard abbreviation of Signal Transduction and Targeted Therapy is Signal Transduct. Target. Ther.. This abbreviation ('Signal Transduct. Target. Ther.') is well recommended and approved for the purpose of indexing, abstraction, referencing and citing goals. It meets all the essential criteria of ISO 4 standard.

ISO 4 (International Organization for Standardization 4) is an international standard that defines a uniform and consistent system for abbreviating serial publication titles and journals.


How to publish in Signal Transduction and Targeted Therapy


If your research field is/are related to Cancer Research (Q1); Genetics (Q1), then please visit the official website of this journal.


Acceptance Rate


The acceptance rate/percentage of any academic journal/conference depends upon many parameters. Some of the critical parameters are listed below.

  • The demand or interest of researchers/scientists in publishing in a specific Journal/Conference.
  • Peer review complexity and timeline.
  • The mix of unsolicited and invited submissions.
  • The time it takes from manuscript submission to final publication.
  • And Many More.

It is essential to understand that the acceptance rate/rejection rate of papers varies among journals. Some Journals considers all the manuscripts submissions as a basis of acceptance rate computation. On the other hand, few consider the only manuscripts sent for peer review or few even not bother about the accurate maintenance of total submissions. Hence, it can provide a rough estimation only.

The best way to find out the acceptance rate is to reach out to the associated editor or to check the official website of the Journal/Conference.



Frequently Asked Questions (FAQs)


What's the latest impact IF of the Signal Transduction and Targeted Therapy?

Signal Transduction and Targeted Therapy latest impact IF is 18.94. It's evaluated in the year 2022. The highest and the lowest impact IF or impact score of this journal are 18.94 (2022) and 0.00 (2016), respectively, in the last 7 years. Moreover, its average IS is 10.65 in the previous 7 years.


What's the SCImago Journal Rank (SJR) of the Signal Transduction and Targeted Therapy?

The Signal Transduction and Targeted Therapy has an SJR (SCImago Journal Rank) of 6.630, according to the latest data. It is computed in the year 2023. In the past 7 years, this journal has recorded a range of SJR, with the highest being 6.630 in 2022 and the lowest being in 2018. Furthermore, the average SJR of the Signal Transduction and Targeted Therapy over the previous 7-year period stands at 10.65.


What's the latest h-index of the Signal Transduction and Targeted Therapy?

The latest h-index of the Signal Transduction and Targeted Therapy is 83.


Who's the publisher of the Signal Transduction and Targeted Therapy?

The Signal Transduction and Targeted Therapy is published by the Springer Nature, with its country of publication being the United Kingdom.


What's the current ranking of the Signal Transduction and Targeted Therapy?

The Signal Transduction and Targeted Therapy is currently ranked 156 out of 27955 Journals, Conferences, and Book Series in the latest ranking. Over the course of the last 7 years, this journal has experienced varying rankings, reaching its highest position of 156 in 2022 and its lowest position of 34677 in 2017.


What's the abbreviation or short name for the Signal Transduction and Targeted Therapy?

The standard ISO4 abbreviation for the Signal Transduction and Targeted Therapy is Signal Transduct. Target. Ther..


Is the "Signal Transduction and Targeted Therapy" classified as a Journal, Conference and Proceedings, Trade Journal or Book Series?

Signal Transduction and Targeted Therapy is classified as a journal that the Springer Nature publishes.


What's the scope or major areas of the Signal Transduction and Targeted Therapy?

The Signal Transduction and Targeted Therapy encompasses the following areas:

  • Cancer Research
  • Genetics

For a more comprehensive understanding of its scope, check the official website of this journal.


What's the ISSN of the Signal Transduction and Targeted Therapy?

The Signal Transduction and Targeted Therapy is assigned the following International Standard Serial Numbers (ISSN): 20593635, 20959907.


What's the best quartile of the Signal Transduction and Targeted Therapy?

The best quartile for the Signal Transduction and Targeted Therapy is Q1 (2022).


What's the coverage history of the Signal Transduction and Targeted Therapy?

The Signal Transduction and Targeted Therapy coverage history can be summarized as follows: 2016-2022.


Credits and Sources


  • Scimago Journal & Country Rank (SJR), https://www.scimagojr.com/
  • Journal Impact Factor, https://clarivate.com/



Impact Score, h-Index, and Other Important Details of These Journals, Conferences, and Books


Journal/Conference/Workshop/Book Title Type Ranking Publisher h-index Impact Score
Journal of Field Archaeology journal 5639 Maney Publishing 43 2.38
Qualitative Research journal 2108 SAGE Publications Ltd 86 3.97
International Journal of Mathematical Education in Science and Technology journal 10040 Taylor and Francis Ltd. 39 1.33
Materials Research journal 14791 Universidade Federal de Sao Carlos 65 1.62
Journal of Classical Sociology journal 13766 SAGE Publications Ltd 27 0.83
International Journal of Research and Method in Education journal 5180 Taylor and Francis Ltd. 34 2.49
Palaeontographica Abteilung B: Palaeophytologie book series 15138 E. Schweizerbart'sche Verlagsbuchhandlung 16 2.20
Asian Textile Journal trade journal 27455 G P S Kwatra 10 0.01
Oral Radiology journal 9461 Springer Japan 20 2.06
Epigenetics journal 2362 Landes Bioscience 105 4.11

Check complete list




Year wise Impact Score (IS) of Signal Transduction and Targeted Therapy

Impact Score Table

Year Impact Score (IS)
2023/2024 Coming Soon
2022 18.94
2021 17.41
2020 12.91
2019 13.78
2018 6.00
2017 5.52
2016 0.00



Top Journals/Conferences in Cancer Research

Nature Reviews Cancer
Nature Publishing Group | United Kingdom

Cancer Cell
Cell Press | United States

Cell Host and Microbe
Cell Press | United States

Journal of Clinical Oncology
Lippincott Williams and Wilkins Ltd. | United States

Nature Cancer
| United States

Molecular Cancer
BioMed Central Ltd. | United Kingdom

JAMA Oncology
American Medical Association | United States

Journal of Hematology and Oncology
BioMed Central Ltd. | United Kingdom

Journal of the National Cancer Institute
Oxford University Press | United Kingdom

Neuro-Oncology
Oxford University Press | United Kingdom

See All

Top Journals/Conferences in Genetics

Cell
Cell Press | United States

Nature Medicine
Nature Publishing Group | United Kingdom

Nature Reviews Genetics
Nature Publishing Group | United Kingdom

Nature Genetics
Nature Publishing Group | United Kingdom

Nature Reviews Methods Primers
Springer Nature | United States

Genome Biology
BioMed Central Ltd. | United Kingdom

Nature Microbiology
Nature Publishing Group | United Kingdom

Cell Stem Cell
Cell Press | United States

Nucleic Acids Research
Oxford University Press | United Kingdom

Annual Review of Genetics
Annual Reviews Inc. | United States

See All